NCT02253030Recruiting
OCT Angiography in Wet AMD
Optical Coherence Tomography Angiography in Neovascular Age-related Macular Degeneration
Source: ClinicalTrials.gov · Last updated 12 Feb 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The primary goals of this study are to use optical coherence tomography (OCT) angiography (blood vessel mapping) to: 1. diagnose the presence of new blood vessels in wet age-related macular degeneration (AMD) 2. evaluate patients undergoing treatment for wet AMD 3. determine if reduced flow to the choroid is a risk factor for developing wet AMD.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 160 (estimated)
- First submitted
- 25 Sept 2014
- Start date
- Sept 2014
- Primary completion date
- Dec 2026
- Lead sponsor
- Oregon Health and Science University
- Diseases
- Macular degeneration
- NCT number
- NCT02253030
What you commit to
- Study type: Observational
- Planned participants: 160
- From Sept 2014 to the primary completion date, Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous macular laser treatment
Other illness
- Significant kidney disease
Other
- Inability to give informed consent
- Blood pressure greater than 180/110
- Inability to maintain stable fixation during OCT imaging
- Visual acuity worse than 20/200
Who the study is looking for
- Adults aged 50 and older with clinical findings of treatment-naïve (never treated) neovascular AMD with active new blood vessel growth confirmed by clinical testing will be considered
- No evidence of retinal disease
- Refractive error greater than +3.00 diopters or -7.00 diopters (glasses Rx)
- No recent eye surgery in the last 4 months
- No significant cataract to interfere with the quality of the imaging
Age in the registry: 50 years to 100 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Casey Eye Institute, Oregon Health & Science University Coordinator of this site? Confirm its status | Portland | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.